These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 12209757

  • 1. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C, Melzer K, Panageas KS, Li E, Kamino H, Kopf A, Cordon-Cardo C, Osman I, Polsky D.
    Cancer; 2002 Aug 01; 95(3):634-40. PubMed ID: 12209757
    [Abstract] [Full Text] [Related]

  • 2. Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma.
    Henrique R, Azevedo R, Bento MJ, Domingues JC, Silva C, Jerónimo C.
    J Am Acad Dermatol; 2000 Dec 01; 43(6):991-1000. PubMed ID: 11100014
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA, Van Belle P, Elder DE, Murry T, Montone KT, Xu X, Hotz S, Raines S, Ming ME, Wahl P, Guerry D.
    J Clin Oncol; 2005 Nov 01; 23(31):8048-56. PubMed ID: 16258103
    [Abstract] [Full Text] [Related]

  • 6. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A, Melanoma Group of the European Organization for Research and Treatment of Cancer.
    J Natl Cancer Inst; 2006 Apr 05; 98(7):472-82. PubMed ID: 16595783
    [Abstract] [Full Text] [Related]

  • 7. Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer.
    Neri A, Marrelli D, Pedrazzani C, Caruso S, De Stefano A, Mariani F, Megha T, De Marco G, Corso G, Pinto E, Roviello F.
    Eur J Surg Oncol; 2008 Dec 05; 34(12):1299-303. PubMed ID: 18164172
    [Abstract] [Full Text] [Related]

  • 8. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M, Chosia M, Domagała W.
    Pol J Pathol; 1999 Dec 05; 50(4):235-41. PubMed ID: 10721263
    [Abstract] [Full Text] [Related]

  • 9. The role of microsatellites as a prognostic factor in primary malignant melanoma.
    Shaikh L, Sagebiel RW, Ferreira CM, Nosrati M, Miller JR, Kashani-Sabet M.
    Arch Dermatol; 2005 Jun 05; 141(6):739-42. PubMed ID: 15967920
    [Abstract] [Full Text] [Related]

  • 10. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG, Essner R, Wang HJ, Foshag LJ, Morton DL.
    Ann Surg Oncol; 2007 May 05; 14(5):1604-11. PubMed ID: 17333418
    [Abstract] [Full Text] [Related]

  • 11. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.
    Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.
    Eur J Cancer; 2009 Sep 05; 45(14):2537-45. PubMed ID: 19553103
    [Abstract] [Full Text] [Related]

  • 12. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB, Lee RJ, Prescott RJ, Doherty VR.
    Br J Dermatol; 2004 Mar 05; 150(3):523-30. PubMed ID: 15030337
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy and early-stage melanoma.
    Daryanani D, Plukker JT, De Hullu JA, Kuiper H, Nap RE, Hoekstra HJ.
    Cancer; 2003 May 01; 97(9):2248-53. PubMed ID: 12712479
    [Abstract] [Full Text] [Related]

  • 14. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.
    Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S.
    Cancer; 2005 Apr 15; 103(8):1693-700. PubMed ID: 15751018
    [Abstract] [Full Text] [Related]

  • 15. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.
    Arch Dermatol; 2008 Apr 15; 144(4):462-7. PubMed ID: 18427039
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
    de Almeida LS, Requena L, Rütten A, Kutzner H, Garbe C, Pestana D, Gomes MM.
    Am J Dermatopathol; 2008 Jun 15; 30(3):207-15. PubMed ID: 18496419
    [Abstract] [Full Text] [Related]

  • 20. MIB-1 in endometrial carcinoma: prognostic significance with 5-year follow-up.
    Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z, Crabtree W.
    Gynecol Oncol; 1999 Dec 15; 75(3):432-6. PubMed ID: 10600302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.